The care of advanced NSCLC (NSCLC) has been transformed by the drug, a specific cancer treatment.Yet, researchers and caregivers continue to prioritize the challenge of extending the usefulness of this medication.This article sets out to examine various methods and requirements for achieving this aim, such as the improvement of medication distribution, the advancement of tumor targeting, the understanding of resistance mechanisms, and the optimization of dosing regimens.Through focusing on these core elements, we can ensure that the drug retains its status as an effective care choice for patients with NSCLC.improvement…
